» Articles » PMID: 21437183

Relation of Subjective Quality of Life to Motor Symptom Profile in Parkinson's Disease

Overview
Journal Parkinsons Dis
Publisher Wiley
Date 2011 Mar 26
PMID 21437183
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) presents with extensive heterogeneity in symptomatology, inviting examination of disease subtypes. One significant categorization is by whether patients present at onset with tremor as the dominant symptom (TD) or with nontremor symptoms (NTD). We examined differences in quality of life between TD and NTD patients using the Parkinson's Disease Questionnaire-39 (PDQ-39), correlating performance with aspects of motor function as indexed by the Unified Parkinson's Disease Rating Scale (UPDRS). Participants included 35 nondemented individuals (19 TD, 16 NTD) matched on clinical and demographic characteristics. NTD had significantly lower overall PDQ-39 scores, particularly for the mobility subscale. Several UPDRS subscale scores significantly correlated with quality of life, especially for NTD. Further, the correlations were driven by nontremor type symptoms, even in TD patients. Determining reliable subtypes of PD may aid in prognosis and treatment optimization, thereby enhancing quality of life in afflicted individuals.

Citing Articles

Effects of Speed-Based Interventions to Reduce Bradykinesia in Individuals with Parkinson's Disease: A Systematic Review Protocol.

Benfica P, Scianni A, Magalhaes J, Brito S, Martins J, Faria C Brain Sci. 2025; 14(12.

PMID: 39766397 PMC: 11674304. DOI: 10.3390/brainsci14121198.


The effect of Non-Motor symptoms on Health-Related quality of life in patients with young onset Parkinson's Disease: A single center Vietnamese Cross-Sectional study.

Tran T, Le Ha U, Nguyen T, Nguyen T, Vo K, Dang T Clin Park Relat Disord. 2021; 5:100118.

PMID: 34927047 PMC: 8649388. DOI: 10.1016/j.prdoa.2021.100118.


A collaborative approach to exercise provision for people with Parkinson's - a feasibility and acceptability study of the PDConnect programme [version 2; peer review: 2 approved].

Jones J, Alexander L, Hancock E, Cooper K AMRC Open Res. 2021; 2021(2):29.

PMID: 34136750 PMC: 7610987. DOI: 10.12688/amrcopenres.12936.2.


Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review.

Tsunemi T, Oyama G, Saiki S, Hatano T, Fukae J, Shimo Y Mov Disord. 2021; 36(8):1759-1771.

PMID: 33899262 PMC: 9290931. DOI: 10.1002/mds.28595.


Characterizing Advanced Parkinson's Disease: Romanian Subanalysis from the OBSERVE-PD Study.

Szasz J, Jianu D, Simu M, Constantin V, Dulamea A, Onuk K Parkinsons Dis. 2021; 2021:6635618.

PMID: 33564391 PMC: 7850828. DOI: 10.1155/2021/6635618.


References
1.
Montel S, Bonnet A, Bungener C . Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease. J Geriatr Psychiatry Neurol. 2009; 22(2):95-102. DOI: 10.1177/0891988708328219. View

2.
Peto V, Jenkinson C, Fitzpatrick R, Greenhall R . The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1995; 4(3):241-8. DOI: 10.1007/BF02260863. View

3.
HOEHN M, Yahr M . Parkinsonism: onset, progression and mortality. Neurology. 1967; 17(5):427-42. DOI: 10.1212/wnl.17.5.427. View

4.
Beck A, Steer R, Ball R, Ranieri W . Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996; 67(3):588-97. DOI: 10.1207/s15327752jpa6703_13. View

5.
Levy G, Louis E, Cote L, Perez M, Mejia-Santana H, Andrews H . Contribution of aging to the severity of different motor signs in Parkinson disease. Arch Neurol. 2005; 62(3):467-72. DOI: 10.1001/archneur.62.3.467. View